Cargando…
Assessing strategies to target screening for advanced liver fibrosis among overweight and obese patients
AIM: The optimal screening strategy for advanced liver fibrosis in overweight and obese patients is unknown. The aim of this study is to compare the performance of different strategies to select patients at high risk of advanced liver fibrosis for screening using non-invasive tools. METHODS: All pat...
Autores principales: | Bril, Fernando, Godinez Leiva, Eddison, Lomonaco, Romina, Shrestha, Sulav, Kalavalapalli, Srilaxmi, Gray, Meagan, Cusi, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400455/ https://www.ncbi.nlm.nih.gov/pubmed/36017449 http://dx.doi.org/10.20517/mtod.2022.08 |
Ejemplares similares
-
MON-644 Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Type 2 Diabetes Mellitus
por: Fanous, Nada, et al.
Publicado: (2020) -
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening
por: Lomonaco, Romina, et al.
Publicado: (2021) -
FRI029 Chronic Free Fatty Acid Elevation Is Associated With An Overcompensatory Increase In Hepatic Mitochondrial Function In Patients With Overweight Or Obesity
por: Bril, Fernando, et al.
Publicado: (2023) -
Severe Disease Activity and Liver Fibrosis Are Associated With a Lack of Hepatic Mitochondrial Adaptation in Patients With NASH
por: Kalavalapalli, Srilaxmi, et al.
Publicado: (2021) -
OR02-1 Differences in HDL Particle Composition in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) and Advanced Liver Fibrosis May Explain Higher Cardiovascular Risk
por: Collier, Timothy, et al.
Publicado: (2022)